[1]张 杨.肝功与血脂血清学指标水平检验在脂肪肝诊断中的应用[J].医学信息,2020,33(01):169-170.[doi:10.3969/j.issn.1006-1959.2020.01.056]
　ZHANG Yang.Application of Liver Function and Serum Lipid Levels in Diagnosis of Fatty Liver[J].Medical Information,2020,33(01):169-170.[doi:10.3969/j.issn.1006-1959.2020.01.056]
点击复制

肝功与血脂血清学指标水平检验在脂肪肝诊断中的应用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年01期
页码:
169-170
栏目:
诊疗技术
出版日期:
2020-01-01

文章信息/Info

Title:
Application of Liver Function and Serum Lipid Levels in Diagnosis of Fatty Liver
文章编号:
1006-1959（2020）01-0169-02
作者:
张 杨
（天津市南开区南开中医院检验科，天津 300102）
Author(s):
ZHANG Yang
(Department of Laboratory Medicine,Nankai Traditional Chinese Medicine Hospital,Tianjin 300102,China)
关键词:
肝功; 血清学指标; 脂肪肝
Keywords:
Liver function; Serological index; Fatty liver
分类号:
R575.5
DOI:
10.3969/j.issn.1006-1959.2020.01.056
文献标志码:
A
摘要:
目的 研究肝功与血脂血清学指标水平检验在脂肪肝诊断中的应用。方法 选取2018年1月~2019年1月在我院治疗的35例脂肪肝患者设为脂肪肝组，另选取同期在我院健康体检者35例为对照组，比较两组天冬氨酸氨基转移酶（AST）、丙氨酸氨基转移酶（ALT）、总胆固醇（TC）、甘油三酯（TG）、高密度脂蛋白胆固醇（HDL-C）、低密度脂蛋白胆固醇（LDL-C）。结果脂肪肝组AST（81.55 6.82）U/L、ALT（57.23±7.85）U/L水平高于对照组（41.17±6.19）U/L、（25.88±5.86）U/L，差异有统计学意义（P＜0.05）；脂肪肝组TC（6.86±1.31）mmol/L、TG（2.36±1.22）mmol/L、LDL-C（3.98 1.31）mmol/L水平高于对照组（4.22±1.08）mmol/L、(1.23±0.65)mmol/L、(3.98±1.31)mmol/L，HDL-C（1.06±0.78）mmol/L低于对照组(1.06±0.78)mmol/L，差异有统计学意义（P＜0.05）。结论 脂肪肝患者肝功与血脂血清学指标水平与健康者存在差异，临床可通过筛查肝功与血脂血清学指标脂肪肝，为早期诊治提供参考依据。
Abstract:
Objective To study the application of liver function and serum lipid levels in the diagnosis of fatty liver. Methods 35 patients with fatty liver treated in our hospital from January 2018 to January 2019 were selected as the fatty liver group, and 35 healthy patients who underwent physical examination in our hospital during the same period were selected as the control group. Aspartate aminotransfer Enzymes(AST), alanine aminotransferase (ALT), total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C).Results The levels of AST (81.556.82) U / L and ALT (57.23±7.85) U/L in the fatty liver group were higher than those in the control group (41.17±6.19) U/L and (25.88±5.86) U/L,the difference was statistically significant (P<0.05); the levels of TC (6.86±1.31) mmol/L, TG(2.36±1.22) mmol/L, and LDL-C (3.981.31) mmol/L were higher in the fatty liver group than in the control group(4.22±1.08) mmo /L, (1.23±0.65) mmol/L, (3.98±1.31) mmol/L, HDL-C(1.06±0.78) mmol/L is lower than the control group (1.06±0.78) mmol/L,the difference was statistically significant(P<0.05).Conclusion The serum levels of liver function and lipids in patients with fatty liver are different from those in healthy subjects. Screening for liver function and serum lipids in patients with fatty liver can provide a reference for early diagnosis and treatment.

参考文献/References:

[1]刘玉栋,姜文静,李润红.微信随访对健康体检人群脂肪肝患者的影响[J].中华健康管理学杂志,2016,10(4):316-320. [2]周会杰.脂肪肝肝功与血清学指标水平检验的临床意义探究[J].泰山医学院学报,2017,38(10):1177-1178. [3]马占军.脂肪肝患者肝功酶学指标、血糖及血脂检测结果及其临床意义[J].国际检验医学杂志,2017,38(16):2227-2228, 2231. [4]孙丽明.肝功能与血脂血清学指标水平检验在脂肪肝诊断中的应用探析[J].中国现代药物应用,2017,11(13):55-56. [5]任清波,郇述玲,陈晶晶,等.非酒精性单纯性脂肪肝患者肝功及血脂代谢情况分析[J].山东医药,2016,56(17):92-93.

相似文献/References:

[1]刘旗旗,张照如.发热伴血小板减少综合征的死亡预测模型建立[J].医学信息,2023,36(11):21.[doi:10.3969/j.issn.1006-1959.2023.11.004]
　LIU Qi-qi,ZHANG Zhao-ru.Establishment of Death Prediction Model for Severe Fever with Thrombocytopenia Syndrome[J].Medical Information,2023,36(01):21.[doi:10.3969/j.issn.1006-1959.2023.11.004]

更新日期/Last Update: 2020-01-01